Nuclear beta-catenin anddiffuse glutamine synthetase staining, albeit weaker in intensity than glypican3, is a hallmark feature of tumor cells, specifically those of epithelialsubtypes.5,19 As tumors move along the differentiation pathway, thestaining pattern necessarily changes. The gene discussed is CTNNB1; the disease is neoplasm.